Source: Korea Biomedical Review

Thermo Fisher Scientific: ENCell and Thermo Fisher Scientific discuss expanded collaboration in cell and gene therapy field

ENCell, a Korean CDMO and new drug development company specializing in advanced biopharmaceuticals, said it discussed strengthening research and development cooperation in the cell and gene therapy (CGT) sector with Thermo Fisher Scientific.The discussions were held in conjunction with the opening o

Read full article »
Annual Revenue
$10-50B
Employees
100K-9.9M
Marc N. Casper's photo - Chairman & CEO of Thermo Fisher Scientific

Chairman & CEO

Marc N. Casper

CEO Approval Rating

91/100

Read more